News
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take post-Covid, changes to the Vaccine Advisory Committee and much more.
FDA Commissioner Marty Makary suggests his agency may expedite drug reviews for manufacturers reducing U.S. prices to global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results